THALIDOMIDE TREATMENT PREVENTS CHRONIC GRAFT REJECTION AFTER AORTIC TRANSPLANTATION IN RATS

BACKGROUND: Cardiac allograft vasculopathy (CAV) affects approximately 30% of cardiac transplant patients at five years post-transplantation. To date there are few CAV treatment or prevention options, none of which are highly effective. The aim of the study was to investigate the effect of thalidomi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transpl Int
Autors principals: Miller, Katharine K., Wang, Dong, Hu, Xiaomeng, Hua, Xiaoqin, Deuse, Tobias, Neofytou, Evgenios, Renne, Thomas, Velden, Joachim, Reichenspurner, Hermann, Schrepfer, Sonja, Bernstein, Daniel
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5643223/
https://ncbi.nlm.nih.gov/pubmed/28672061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tri.13004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars